February 25, 2022, Shanghai —Boan Biotech today announced that Boyounuo® (Bevacizumab Injection), an anticancer biologic, has been approved by China’s National Medical Products Administration (...
Luye Pharma Group today announced that the first patient has been enrolled in a Phase I clinical trial for BA1105, an investigational anti-Claudin18.2 antibody developed by its subsidiary Boan Biotech...
Shanghai, December 14, 2021—Luye Pharma Group announced that the clinical trial application for BA1201, an anti-PD-L1/TGF-β bispecific antibody developed by its subsidiary Boan Biotech, has been...
The findings about BA1106, a fully human monoclonal anti-CD25 antibody developed by Boan Biotech, a subsidiary of Luye Pharma Group, were published in Scientific Reports, which is a journal of the Nat...
Boan Biotech, a subsidiary of Luye Pharma Group, announced today that it has signed a Memorandum of Understanding with Merck, a world-leading science and technology company, under which the two partie...
Clinical trials of the drug in Europe and the U.S. are making good progressOctober 13, 2021, Shanghai -- Luye Pharma Group announced that the marketing authorization application for the Denosumab Inje...
Luye Pharma Group today announced that BA1105, a novel antibody developed by its subsidiary Boan Biotech, has been approved by the Center for Drug Evaluation (CDE) of China's National Medical Prod...
September 27, 2021, Shanghai, China – Luye Pharma Group today announced that Dulaglutide Injection (BA5101) developed in-house by Boan Biotech, a subsidiary of the Group, has obtained approval f...
September 26, 2021, Boston, USA - Boan Biotech, a subsidiary of Luye Pharma Group, will orally present the pre-clinical data of its proprietary CD3+ T-cell engager platform and CEA/CD3 bispecific anti...
Boan Biotech has announced significant progress with LY-CovMab, a neutralizing antibody independently developedfor the treatment of COVID-19. LY-CovMab has been preliminarily validated for effectively...
No.39 Keji Avenue High-Tech Industrial Development Zone Yantai, Shandong Province, China
（86）0535-4379111
boanbiotech@boan-bio.com
Follow me
鲁公网安备37069102000284
ICP备：鲁ICP备2021004064号-1
